Regarding the Medical Fee Revision – PT-OT

This time"Regarding the Medical Fee Revision"M&A Medical's perspective on this news goes beyond a mere report of system changes, andsuggests a structural turning point in Japanese medical institution management."Stricter facility standards" and "review of nursing staffing levels" strongly imply that it may become difficult for small-scale medical institutions to maintain their current business models. This will likely accelerate the transition from an era where individual clinics and hospitals survive independently to an era that demands groups with more efficient and robust management foundations.

In the context of medical M&A and business succession, this revisionreaffirms the importance of M&A as a "survival strategy."In particular, the "economies of scale" mentioned, such as maintaining facility standards and dispersing the burden of equipment investment, can be an effective option for managers facing succession issues when direct succession is difficult. Even if a successor cannot be found, it shows a path to continue contributing to regional healthcare and reduce management risks by joining an existing medical group.

A concrete takeaway for medical institution managers and those facing succession issues isto view the medical fee revision as an "opportunity to strengthen management capabilities."It is necessary to evaluate the "sustainability" of one's own institution not just in terms of immediate revision responses, but also from a medium-to-long-term perspective, and to actively consider M&A or group formation if necessary. In particular, utilizing tax schemes such as "transitioning to a Specified Medical Corporation or Social Medical Corporation" is an extremely important factor in enhancing business continuity after succession. It is crucial to objectively assess your institution's "strengths" and "weaknesses" in the current business environment and to envision the optimal future with experts.